In 2007, the US company, Purdue Pharma, pleaded guilty to misleading governmental regulators, doctors, and patients about the addictiveness of its opioid product, Oxycodone, known under the brand name OxyContin (Meier 2007, 2018). Purdue Pharma advertised OxyContin as less addictive because it had…
